Hemp-derived synthetic forms of THC, the psychoactive element in cannabis, do not meet the federal definition of hemp and are therefore controlled substances, the U.S. Drug Enforcement Administration (DEA) has […]
DEA asserts hemp-derived THC products are controlled substances Read More »
A regional court in Italy has upheld a lawsuit filed by four cannabis associations, overturning a decree issued one year ago that classified hemp as a narcotic in contravention of
Italian trade groups cheer court ruling that hemp is not a narcotic Read More »
Amended legislation in Zimbabwe has removed industrial hemp from the country’s list of dangerous drugs and set the defining line between marijuana and hemp at 1.0%. The legislation, the Criminal
Zimbabwe strikes hemp from drugs list, sets THC limit at 1.0% Read More »
While North Carolina hemp farmers all but abandoned the flower market, flower-derived CBD products continue to flood the state, underscoring consumer safety threats amid a yawning regulatory gap. Growing and
NC grapples with CBD, as downsized hemp industry re-sets to fiber Read More »
Hong Kong has banned CBD, adopting harsh criminal punishment aligned with China’s zero-tolerance policy which led to a ban on the mainland last year. The new policy, approved last October
Following China, Hong Kong criminalizes CBD under harsh penalties Read More »
More than 400 CBD products have now been stricken from a public list by UK food safety officials, and may not be sold to consumers. The UK’s Food Standards Agency
More than 400 CBD products are now barred from sale in UK Read More »
Saying federal safety standards are insufficient to manage the CBD industry, the U.S. Food and Drug Administration (FDA) has called on Congress to set rules for the products through legislation.
FDA says it can’t manage regulation of CBD, calls on Congress to act Read More »
The U.S. Food and Drug Administration (FDA) says it is only months away from finalizing recommendations for how cannabis should best be regulated and whether additional legislation from Congress is
FDA recommendations on cannabis could signal progress for CBD Read More »
The maker of CBD prescription drug Epidiolex has filed a lawsuit in the USA alleging patent infringement. GW Research Ltd, a subsidiary of Ireland-based Jazz Pharmaceuticals, claims that more than
Epidiolex maker files suit in U.S. to protect its patents Read More »
A New Jersey state senator has introduced a bill to regulate delta-8 THC, calling the synthetic compound “the bathtub gin of the cannabis space” as he warned many such products might
Delta-8 is ‘bathtub gin of the cannabis space,’ New Jersey lawmaker warns Read More »
